JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB273743

人CXCL8 knockout PC-3 cell line

Human CXCL8 knockout PC-3 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

CXCL8 KO cell line available to order. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 22% 11 bp deletion, 24% 7 bp deletion, 54% 2 bp deletion in exon 2. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.

查看别名

(Ala-IL-8)77, (Ser-IL-8)72, 9.00E+03, Beta thromboglobulin like protein, C-X-C motif chemokine 8, CEF-4, CXCL8, Emoctakin, GCP-1, GCP/IL-8 protein I, GCP/IL-8 protein II, GCP/IL-8 protein III, GCP/IL-8 protein IV, GCP/IL-8 protein V, GCP/IL-8 protein VI, Granulocyte chemotactic protein 1, IL-8(1-77), IL-8(9-77), IL8/NAP1 form I, IL8/NAP1 form II, IL8/NAP1 form III, IL8/NAP1 form IV, IL8/NAP1 form V, IL8/NAP1 form VI, IL8_HUMAN, Inteleukin 8, LECT, LUCT, LYNAP, Lymphocyte-derived neutrophil-activating factor, MDNCF, MDNCF-b, MDNCF-c, MONAP, Monocyte-derived neutrophil chemotactic factor, Monocyte-derived neutrophil-activating peptide, NAP-1, Neutrophil activating peptide 1, Neutrophil-activating factor, Neutrophil-activating protein 1, Protein 3-10C, SCYB 8, Small inducible cytokine subfamily B member 8, T-cell chemotactic factor, TSG 1, chemokine, CXC motif, ligand 8

6 Images
Western blot - Human CXCL8 knockout PC-3 cell line (AB273743)
  • WB

Lab

Western blot - Human CXCL8 knockout PC-3 cell line (AB273743)

Lanes 1 - 6 : Merged signal (red and green). Green - ab235584 observed at 10 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.

ab235584 was shown to react with IL-8 in wild-type PC-3 cells in Western blot with loss of signal observed in CXCL8 knockout cell line ab273743 (knockout cell lysate ab275520). Wild-type PC-3 and CXCL8 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab235584 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 ° at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-IL-8 antibody [EPR22994-255] (<a href='/products/primary-antibodies/il-8-antibody-epr22994-255-ab235584'>ab235584</a>) at 1/1000 dilution

Lane 1:

Wild-type PC-3 Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 &mu;g/ml, 5 h) cell lysate at 30 µg

Lane 2:

Wild-type PC-3 LPS-treated (2 &mu;g/ml, 6 h) with Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) (5 &mu;g/ml, 5 h) cell lysate at 30 µg

Lane 2:

Western blot - Human CXCL8 knockout PC-3 cell line (ab273743)

Lane 3:

CXCL8 knockout PC-3 Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 &mu;g/ml, 5 h) cell lysate at 30 µg

Lane 4:

CXCL8 knockout PC-3 LPS-treated (2 &mu;g/ml, 6 h) with Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) (5 &mu;g/ml, 5 h) cell lysate at 30 µg

Lane 5:

A431 cell lysate at 30 µg

Lane 6:

HCT116 cell lysate at 30 µg

Predicted band size: 11 kDa

Observed band size: 10 kDa

false

Sandwich ELISA - Human CXCL8 knockout PC-3 cell line (AB273743)
  • sELISA

Lab

Sandwich ELISA - Human CXCL8 knockout PC-3 cell line (AB273743)

Human IL-8 concentration was interpolated from the standard curve. Supernatants from cell culture samples were serially diluted and assessed by the Human IL-8 ELISA kit (ab214030). Wild-type PC-3 cells and CXCL8 knockout PC-3 cells (ab273743) were assessed in duplicate (n=2) and were either treated with 2 μg/ml LPS for 6 hours to induce expression of IL-8 or not treated with LPS. Data are represented as the mean and error bars represent standard deviation.

Next Generation Sequencing - Human CXCL8 knockout PC-3 cell line (AB273743)
  • NGS

Supplier Data

Next Generation Sequencing - Human CXCL8 knockout PC-3 cell line (AB273743)

Allele-2 : 7bp deletion in exon 2.

Next Generation Sequencing - Human CXCL8 knockout PC-3 cell line (AB273743)
  • NGS

Supplier Data

Next Generation Sequencing - Human CXCL8 knockout PC-3 cell line (AB273743)

Allele-3 : 2bp deletion in exon 2.

Next Generation Sequencing - Human CXCL8 knockout PC-3 cell line (AB273743)
  • NGS

Supplier Data

Next Generation Sequencing - Human CXCL8 knockout PC-3 cell line (AB273743)

Allele-1 : 11bp deletion in exon 2.

Immunocytochemistry/ Immunofluorescence - Human CXCL8 knockout PC-3 cell line (AB273743)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Human CXCL8 knockout PC-3 cell line (AB273743)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized CXCL8 KO PC-3 (CXCL8 knockout human prostate adenocarcinoma epithelial cell), ab273743 cells labelling IL-8 with ab322732 at 1/2000 (0.246 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/ml dilution (Green).

Confocal image showing increased cytoplasmic staining in wildype PC-3 cells treated with Lipopolysaccharide (2 ug/ml) and Brefeldin A (5 ug/ml) for 5 hours (shown in green). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Magenta). The Nuclear counterstain was DAPI (Blue).

Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/ml dilution.

关键信息

细胞类型

PC-3

种属

Human

组织

Prostate

形式

Liquid

form

敲除验证

Next Generation Sequencing,Western blot

突变描述

Knockout achieved by using CRISPR/Cas9, Homozygous: 22% 11 bp deletion, 24% 7 bp deletion, 54% 2 bp deletion in exon 2

疾病

Adenocarcinoma

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

产品详情

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

规格

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab273743-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab275472 Human wild-type PC-3 cell line", "number":"AB273743-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab273743 Human CXCL8 knockout PC-3 cell line", "number":"AB273743-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab273743-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab273743 Human CXCL8 knockout PC-3 cell line", "number":"AB273743-CMP01", "productcode":"" } ] } } }

性能和储存信息

基因名称
CXCL8
基因编辑类型
Knockout
基因编辑方法
CRISPR technology
敲除验证
Next Generation Sequencing, Western blot
运输条件
Dry Ice
推荐的短期储存条件
-196°C
推荐的长期储存条件
-196°C

处理步骤

初始处理指南

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

传代培养指南
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
培养基

F-12K + 10% FBS

低温储藏试剂

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

IL-8 also known as CXCL8 is a cytokine with a molecular weight of approximately 8 kDa. It belongs to the CXC chemokine family and plays a role in the recruitment of neutrophils to sites of inflammation. Cells like monocytes macrophages and endothelial cells express IL-8 after activation by pro-inflammatory signals. The protein exhibits high expression in cells associated with the immune response and inflammation serving as a signaling molecule between these cell types.
Biological function summary

IL-8 functions as a chemoattractant for neutrophils and lymphocytes facilitating their movement towards the site of infection or injury. It does not form part of a larger protein complex but operates individually to enhance immune cell migration. IL-8 possesses unique binding motifs allowing it to interact with specific receptors namely CXCR1 and CXCR2 on target cells. This binding triggers cellular responses leading to effective immune surveillance and response to inflammatory stimuli.

Pathways

IL-8 operates within important inflammatory and immune response pathways. It forms a part of the NF-κB signaling cascade which activates in response to stress signals promoting the expression of other inflammatory mediators. Additionally it engages in the mitogen-activated protein kinase (MAPK) pathway influencing cellular responses such as proliferation and differentiation. The interaction of IL-8 with these pathways highlights its role in modulating immune responses and highlights its interaction with other proteins such as TNF-α and IL-1β.

IL-8 shows a strong association with conditions like rheumatoid arthritis and chronic obstructive pulmonary disease (COPD). It acts as a biomarker for these diseases often correlating with disease severity and inflammation levels. In rheumatoid arthritis IL-8 contributes to joint inflammation and degradation while in COPD it enhances airway inflammation and tissue damage. The cytokine's involvement in these diseases connects it with other inflammatory mediators such as MMPs and leukotrienes which collectively exacerbate disease pathology.

细胞培养

生物安全等级

EU: 1 US: 1

贴壁/悬浮

Adherent

性别

Male

产品实验方案

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com